Increasing incidence of pouchitis between 1996 and 2018: A population-based Danish cohort study

Background and aims: Current knowledge regarding the epidemiology of pouchitis is based on highly selected, mostly single-center, patient cohorts. The objective of the present study was to prospectively determine the population-based incidence of pouchitis in patients with ulcerative colitis in the first 2 years after ileal pouch-anal anastomosis (IPAA) and analyze time trends of the incidence of pouchitis.
Methods: Using national registries, the authors established a population-based cohort of all Danish patients undergoing proctocolectomy with IPAA for ulcerative colitis between 1996 and 2018. The primary outcome was the development of pouchitis within the first 2 years after surgery, evaluated by time period. Kaplan-Meier and Cox proportional hazard modeling were used to evaluate the time to development of pouchitis.
Results: Overall, 1664 patients underwent an IPAA. The cumulative incidence of pouchitis in the 2 years after IPAA increased throughout the study period, from 40% in the period from 1996 to 2000 (95% confidence interval [CI]: 35–46%) to 55% in the period from 2015 to 2018 (95% CI: 48–63%). Patients undergoing surgery between 2015 and 2018 also showed an increased risk of pouchitis compared with the earliest study period (1996–2000) after adjusting for sex, age, and socioeconomic status (hazard ratio = 1.57; 95% CI: 1.20–2.05).

Conclusions: This population-based study showed a 15% absolute and 38% relative increase in the incidence of pouchitis among patients undergoing surgery between 1996 and 2018, with the greatest cumulative incidence of pouchitis shown in the most recent era (2015–2018). The striking increase in the incidence of pouchitis highlights the need for further research into causes and prevention of pouchitis.

E.L. Barnes, M.D., Assistant Professor of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA,
E-Mail: edward_barnes@med.unc.edu

DOI: DOI: 10.1016/j.cgh.2022.04.015

Back to overview

this could be of interest:

Colon to Rectum

Post-COVID-19 irritable bowel syndrome

Gut. 2023;72(3):484–92

Marasco G, Cremon C, Barbaro MR, Cacciari G, Falangone F, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, Mohamed SY, Ricci C, Bellini M, Rahman MM, Melcarne L, Santos J, Lobo B, Bor S, Yapali S, Akyol D, Sapmaz FP, Urun YY, Eskazan T, Celebi A, Kacmaz H, Ebik B, Binicier HC, Bugdayci MS, Yağcı MB, Pullukcu H, Kaya BY, Tureyen A, Hatemi İ, Koc ES, Sirin G, Calıskan AR, Bengi G, Alıs EE, Lukic S, Trajkovska M, Hod K, Dumitrascu D, Pietrangelo A, Corradini E, Simren M, Sjölund J, Tornkvist N, Ghoshal UC, Kolokolnikova O, Colecchia A, Serra J, Maconi G, De Giorgio R, Danese S, Portincasa P, Di Sabatino A, Maggio M, Philippou E, Lee YY, Salvi D, Venturi A, Borghi C, Zoli M, Gionchetti P, Viale P, Stanghellini V, Barbara G; GI-COVID19 study group

Go to article

Colon to Rectum

Early management of acute severe UC in the biologics era: Development and international validation of a prognostic clinical index to predict steroid response

Gut. 2023;72(3):433–42